These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 36872367)

  • 1. Effect of digoxin on all-cause and cardiovascular mortality in patients with atrial fibrillation with and without heart failure: an umbrella review of systematic reviews and 12 meta-analyses.
    Gazzaniga G; Menichelli D; Scaglione F; Farcomeni A; Pani A; Pastori D
    Eur J Clin Pharmacol; 2023 Apr; 79(4):473-483. PubMed ID: 36872367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digoxin Is Associated With Increased All-cause Mortality in Patients With Atrial Fibrillation Regardless of Concomitant Heart Failure: A Meta-analysis.
    Wang ZQ; Zhang R; Chen MT; Wang QS; Zhang Y; Huang XH; Wang J; Yan JH; Li YG
    J Cardiovasc Pharmacol; 2015 Sep; 66(3):270-5. PubMed ID: 26348825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-Analysis of Effects of Digoxin on Survival in Patients with Atrial Fibrillation or Heart Failure: An Update.
    Vamos M; Erath JW; Benz AP; Lopes RD; Hohnloser SH
    Am J Cardiol; 2019 Jan; 123(1):69-74. PubMed ID: 30539748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.
    Sethi NJ; Nielsen EE; Safi S; Feinberg J; Gluud C; Jakobsen JC
    PLoS One; 2018; 13(3):e0193924. PubMed ID: 29518134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review and meta-analysis of mortality and digoxin use in atrial fibrillation.
    Qureshi W; O'Neal WT; Soliman EZ; Al-Mallah MH
    Cardiol J; 2016; 23(3):333-43. PubMed ID: 27064796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digoxin-associated mortality: a systematic review and meta-analysis of the literature.
    Vamos M; Erath JW; Hohnloser SH
    Eur Heart J; 2015 Jul; 36(28):1831-8. PubMed ID: 25939649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes in patients with atrial fibrillation treated with digoxin, according to the presence of heart failure: Insights from the MISOAC-AF trial.
    Botis M; Kartas A; Samaras A; Akrivos E; Vrana E; Liampas E; Papazoglou AS; Moysidis DV; Papanastasiou A; Baroutidou A; Karvounis H; Tzikas A; Parissis J; Drakos SG; Giannakoulas G
    Hellenic J Cardiol; 2022; 68():25-32. PubMed ID: 36037999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased All-Cause Mortality Associated With Digoxin Therapy in Patients With Atrial Fibrillation: An Updated Meta-Analysis.
    Chen Y; Cai X; Huang W; Wu Y; Huang Y; Hu Y
    Medicine (Baltimore); 2015 Dec; 94(52):e2409. PubMed ID: 26717399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of digoxin on mortality in patients with atrial fibrillation: Overview of systematic reviews.
    Baker WL; Sobieraj DM; DiDomenico RJ
    Pharmacotherapy; 2021 Apr; 41(4):394-404. PubMed ID: 33544894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The impact of digoxin on the long-term outcomes in patients with coronary artery disease and atrial fibrillation].
    Qiao Y; Wang Y; Jiang CX; Li SN; Sang CH; Tang RB; Long DY; Wu JH; He L; Du X; Dong JZ; Ma CS
    Zhonghua Nei Ke Za Zhi; 2021 Sep; 60(9):797-805. PubMed ID: 34445815
    [No Abstract]   [Full Text] [Related]  

  • 11. Relation of digoxin use in atrial fibrillation and the risk of all-cause mortality in patients ≥65 years of age with versus without heart failure.
    Shah M; Avgil Tsadok M; Jackevicius CA; Essebag V; Behlouli H; Pilote L
    Am J Cardiol; 2014 Aug; 114(3):401-6. PubMed ID: 24950677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Digoxin on Mortality in Patients With Atrial Fibrillation Stratified by Heart Failure: Findings From Gulf Survey of Atrial Fibrillation Events in the Middle East.
    Al-Zakwani I; Panduranga P; Zubaid M; Sulaiman K; Rashed WA; Alsheikh-Ali AA; AlMahmeed W; Shehab A; Al Qudaimi A; Asaad N; Amin H
    J Cardiovasc Pharmacol Ther; 2016 May; 21(3):273-9. PubMed ID: 26341119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digoxin Impact on Heart Failure Patients with Atrial Fibrillation.
    Gerakaris A; Mulita F; Koniari I; Artopoulou E; Mplani V; Tsigkas G; Abo-Elseoud M; Kounis N; Velissaris D
    Med Arch; 2022 Feb; 76(1):23-28. PubMed ID: 35422570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Digoxin Therapy on Mortality in Patients With Atrial Fibrillation: An Updated Meta-Analysis.
    Wang X; Luo Y; Xu D; Zhao K
    Front Cardiovasc Med; 2021; 8():731135. PubMed ID: 34660731
    [No Abstract]   [Full Text] [Related]  

  • 15. Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).
    Washam JB; Stevens SR; Lokhnygina Y; Halperin JL; Breithardt G; Singer DE; Mahaffey KW; Hankey GJ; Berkowitz SD; Nessel CC; Fox KA; Califf RM; Piccini JP; Patel MR;
    Lancet; 2015 Jun; 385(9985):2363-70. PubMed ID: 25749644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digoxin, mortality, and cardiac hospitalizations in patients with atrial fibrillation and heart failure with reduced ejection fraction and atrial fibrillation: An AF-CHF analysis.
    Elayi CS; Shohoudi A; Moodie E; Etaee F; Guglin M; Roy D; Khairy P;
    Int J Cardiol; 2020 Aug; 313():48-54. PubMed ID: 32320783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased mortality among patients taking digoxin--analysis from the AFFIRM study.
    Whitbeck MG; Charnigo RJ; Khairy P; Ziada K; Bailey AL; Zegarra MM; Shah J; Morales G; Macaulay T; Sorrell VL; Campbell CL; Gurley J; Anaya P; Nasr H; Bai R; Di Biase L; Booth DC; Jondeau G; Natale A; Roy D; Smyth S; Moliterno DJ; Elayi CS
    Eur Heart J; 2013 May; 34(20):1481-8. PubMed ID: 23186806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digoxin use and outcomes after myocardial infarction in patients with atrial fibrillation.
    Kytö V; Saraste A; Rautava P; Tornio A
    Basic Clin Pharmacol Toxicol; 2022 Jun; 130(6):655-665. PubMed ID: 35420260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digoxin treatment is associated with increased total and cardiovascular mortality in anticoagulated patients with atrial fibrillation.
    Pastori D; Farcomeni A; Bucci T; Cangemi R; Ciacci P; Vicario T; Violi F; Pignatelli P
    Int J Cardiol; 2015 Feb; 180():1-5. PubMed ID: 25460369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digoxin use and clinical outcomes in elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry.
    Guo Y; Kotalczyk A; Wang Y; Lip GYH
    Europace; 2022 Jul; 24(7):1076-1083. PubMed ID: 35025995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.